SCHEMBL7799243

SCHEMBL7799243

COc1cc2cnc(Nc3ccccc3C(F)(F)F)nc2cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.58
LRRK2 Q5S007 3/20 0.50
ULK1 O75385 5/20 0.48
PTK2 Q05397 2/20 0.47
MAP4K1 Q92918 2/20 0.45
KDR P35968 3/20 0.44
AURKA O14965 3/20 0.44
AURKB Q96GD4 2/20 0.44
JAK2 O60674 1/20 0.43
NTRK1 P04629 1/20 0.43
TYK2 P29597 1/20 0.43
JAK3 P52333 1/20 0.43
PTK2B Q14289 1/20 0.43
NTRK3 Q16288 1/20 0.43
NTRK2 Q16620 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
NTSR1 P30989 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7800595 0.84 LRRK2 (0.46) EGFRLRRK2ULK1PTK2AURKA
SCHEMBL7791030 0.84 FLT1 (0.55) EGFRLRRK2PTK2MAP4K1KDR
SCHEMBL7799232 0.82 CSF1R (0.49) EGFRLRRK2PTK2HTTSMN1; SMN2
SCHEMBL7800417 0.81 LRRK2 (0.53) EGFRLRRK2PTK2AURKAAURKB
SCHEMBL1539121 0.81 RET (0.55) EGFRLRRK2KDRAURKAKMT2A
SCHEMBL7790969 0.81 EGFR (0.55) EGFRLRRK2PTK2MAP4K1SMN1; SMN2
SCHEMBL7791014 0.81 C1R (0.51) EGFRLRRK2PTK2KMT2ASMN1; SMN2
SCHEMBL7799235 0.79 CSF1R (0.52) EGFRULK1MAP4K1KDRAURKA
SCHEMBL7757002 0.78 PDGFRB (0.59) EGFRKDRAURKASMN1; SMN2
SCHEMBL15533894 0.78 MAPK8 (0.55) EGFRLRRK2ULK1MAP4K1ULK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed